Enovis Corporation (ENOV)
NYSE: ENOV · Real-Time Price · USD
27.02
-0.94 (-3.36%)
Dec 5, 2025, 4:00 PM EST - Market closed
Enovis Revenue
Enovis had revenue of $548.91M in the quarter ending October 3, 2025, with 8.65% growth. This brings the company's revenue in the last twelve months to $2.23B, up 11.57% year-over-year. In the year 2024, Enovis had annual revenue of $2.11B with 23.46% growth.
Revenue (ttm)
$2.23B
Revenue Growth
+11.57%
P/S Ratio
0.69
Revenue / Employee
$303,145
Employees
7,367
Market Cap
1.55B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.11B | 400.43M | 23.46% |
| Dec 31, 2023 | 1.71B | 144.10M | 9.22% |
| Dec 31, 2022 | 1.56B | 136.91M | 9.60% |
| Dec 31, 2021 | 1.43B | 305.49M | 27.26% |
| Dec 31, 2020 | 1.12B | -2.21B | -66.32% |
| Dec 31, 2019 | 3.33B | 1.13B | 51.73% |
| Dec 31, 2018 | 2.19B | 255.80M | 13.20% |
| Dec 31, 2017 | 1.94B | -1.25B | -39.19% |
| Dec 31, 2016 | 3.19B | -248.60M | -7.24% |
| Dec 31, 2015 | 3.43B | -1.19B | -25.74% |
| Dec 31, 2014 | 4.62B | 417.27M | 9.92% |
| Dec 31, 2013 | 4.21B | 293.35M | 7.50% |
| Dec 31, 2012 | 3.91B | 3.22B | 464.45% |
| Dec 31, 2011 | 693.39M | 151.41M | 27.94% |
| Dec 31, 2010 | 541.99M | 16.96M | 3.23% |
| Dec 31, 2009 | 525.02M | -79.83M | -13.20% |
| Dec 31, 2008 | 604.85M | 98.55M | 19.46% |
| Dec 31, 2007 | 506.31M | 112.70M | 28.63% |
| Dec 31, 2006 | 393.60M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
ENOV News
- 25 days ago - Enovis Corporation (ENOV) Presents at UBS Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 4 weeks ago - Enovis Corporation (ENOV) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Enovis Announces Third Quarter 2025 Results - GlobeNewsWire
- 6 weeks ago - Enovis announces webcast and conference call for Third Quarter 2025 Results and participation in upcoming investor conferences - GlobeNewsWire
- 2 months ago - Enovis completes sale of its Dr. Comfort Footcare Solutions business for proceeds of up to $60 million - GlobeNewsWire
- 3 months ago - Enovis Corporation Announces Time Change for Presentation at Baird 2025 Global Healthcare Conference - GlobeNewsWire
- 3 months ago - Enovis: Healthy Recon Trends Vs. Market Apathy - Seeking Alpha
- 4 months ago - Enovis to Participate in Upcoming Investor Conferences - GlobeNewsWire